[12] Patent
[11] Patent No.:GC0009495  
[45] Date of Publishing the Grant of the Patent: 31/Dec /2018                56/2018  
Number of the Decision to Grant the Patent:2018/142591
Date of the Decision to Grant the Patent:31/Dec/2018

[21] Application No.:GC 2011-17575

[22] Filing Date:15/1/2011

[30] Priority:

[33] State [32] Priority date [31] Priority No.

[72] Inventor: Ivan E. Danhof

[73] Owner: Bespoke Bioscience, LLC, N. Dallas Parkway, Ste 400,14951, TX 75254, Dallas, Not specified

[74] Agent: Suleiman I. Al-Ammar Law Office




Int. Cl.: A61K 31/715, 36/886, 9/14; A61P 35/00, 37/02, 37/04; C08B 37/04 (2006.01)

[56] Cited Documents:

-US 20030096378 A1 (QIU, Z. et al) 22 May 2003  
Examiner: Eng. Sattam M.AlMutairi

[57] Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
No. of claims: 47     No. of figures: 7


Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.